April 14, 2023
Please review the following information received from Cigna.
Since the COVID-19 pandemic began, we have taken important steps to deliver timely accommodations to providers and customers, helping to ensure that customers have continued access to COVID-19 diagnostic services, testing, and treatment in safe settings.
Ending the public health emergency period
As you know, the White House announced their intent to end both the COVID-19 national emergency and public health emergency (PHE) on May 11, 2023.
As a result, Cigna commercial and Cigna Medicare Advantage plan to make the following changes on May 12, 2023:
- Authorizations for facility-to-facility transfers will again be required.
- Patient cost-share will apply to COVID-19 lab tests as well as antiviral and therapeutics approved by the U.S Food & Drug Administration (FDA).
- For most benefit plans, COVID-19 vaccines will be covered at 100 percent under the preventive benefit (same as the flu shot) when customers go to an in-network provider.
- Over-the-counter COVID-19 tests will no longer be covered.
Please know that we continue to monitor for any updates from the administration and continue to evaluate potential additional changes to our ongoing COVID-19 accommodations as a result of the PHE ending.